Abbott Laboratories said on Monday it has begun a correction in the United States for certain FreeStyle Libre 3 and FreeStyle ...

The CMS could use its competitive bidding program to address price concerns, after payments for the devices swelled over five ...

The medtech firm plans to launch its next flagship patch-pump in 2027, and its first fully closed loop system for Type 2 ...

UB researchers have published the first comprehensive meta-review of AI-enhanced wearables for people with prediabetes and ...

According to DataM Intelligence, the Insulin Delivery Devices Market Size reached USD 20.26 billion in 2024 and is projected to reach USD 43.11 billion by 2033, growing at a strong CAGR of 8.8% from ...

AID systems combine an insulin pump with a continuous glucose monitor to automatically adjust insulin levels throughout the ...

Know Labs is on a mission to produce the market’s first ever noninvasive glucose monitoring device. On Wednesday, it got one step closer. The Seattle-based company unveiled the prototype for its ...

Abbott just announced a “medical device correction” for approximately three million glucose sensor monitors in the U.S., ...

Abbot has issued a medical device correction for some of its glucose sensor products after identifying a manufacturing issue that can lead to falsely low glucose readings. The correction affects about ...

Please provide your email address to receive an email when new articles are posted on . School nurses should familiarize themselves with devices used by children with diabetes. Children with diabetes ...

Abbott has launched an effort to replace some of its FreeStyle Libre 3 continuous glucose monitors—following reports of ...

Increasing prevalence of diabetes, growing awareness and education and shift towards personalized medicine are the major factors which drive the global market growth Rise in incidences of diabetes, ...